NanoViricides
NNVC
27 hedge funds and large institutions have $1.42M invested in NanoViricides in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 5 closing their positions.
67% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 3
0.19% less ownership
Funds ownership: 10.77% → 10.58% (-0.19%)
3% less capital invested
Capital invested by funds: $1.47M → $1.42M (-$48.7K)
13% less funds holding
Funds holding: 31 → 27 (-4)
80% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
+$29.2K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$20.1K |
| 3 |
Stifel Financial
St. Louis,
Missouri
|
+$11.7K |
| 4 |
Renaissance Technologies
New York
|
+$9.07K |
| 5 |
Morgan Stanley
New York
|
+$181 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$63K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$17.8K |
| 3 |
Two Sigma Investments
New York
|
-$4.99K |
| 4 |
Simplex Trading
Chicago,
Illinois
|
-$2.25K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
US Bancorp
Minneapolis,
Minnesota
| $49 | – | – | – |
|
|
CSPIA
27
Cary Street Partners Investment Advisory
Richmond,
Virginia
| $17 | – | – | – |
|
|
28
Millennium Management
New York
| – | -$63K | -53,773 | Closed |
|
|
29
Citadel Advisors
Miami,
Florida
| – | -$17.8K | -15,205 | Closed |
|
|
TRCT
30
Tower Research Capital (TRC)
New York
| – | -$2K | -1,526 | Closed |
|
|
ASN
31
Advisory Services Network
Atlanta,
Georgia
| – | -$29 | -25 | Closed |
|
32
Fidelity Investments
Boston,
Massachusetts
| – | -$1 | -1 | Closed |
|
NNVC Hedge Fund Activity: Q2 2023 in Review
27 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in NanoViricides (NNVC) for Q2 2023, worth a combined $1.42M — down 3.3% from $1.47M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of NNVC and 1 opened new positions — a net loss of 4 holders — while 3 trimmed existing stakes and 5 added.
The largest buyer was Two Sigma Securities, opening a new position worth an estimated $29.2K. The largest seller was Millennium Management, exiting entirely with an estimated $63K sold.
- 27 institutional investors held NanoViricides (NNVC) as of Q2 2023, down from 31 in Q1 2023.
- Funds reported $1.42M of NanoViricides stock for Q2 2023, down 3.3% quarter-over-quarter.
- 1 fund opened new NanoViricides positions in Q2 2023 and 5 closed out, a net change of -4 holders.
- The largest NanoViricides buyer in Q2 2023 was Two Sigma Securities, an estimated $29.2K added.
- The largest NanoViricides seller in Q2 2023 was Millennium Management, an estimated $63K sold.
Based on aggregated 13F filings for Q2 2023.